Skip to main content
. 2023 Feb;27(2):119–126. doi: 10.5005/jp-journals-10071-24408

Table 1.

Patient and disease characteristics among survivors and non-survivors

Variables Survivors (n = 116) Non-survivors (n = 84) p-value (Pearson χ2/Fisher's exact test)
Comorbidities
 DM, n (%) 21 (18.1) 37 (44.1) 0.0001
 Hypertension, n (%) 8 (6.9) 19 (22.6) 0.0014
 Cardiovascular disease, n (%) 13 (11.2) 24 (28.5) 0.0019
 Cerebrovascular event, n (%) 4 (3.4) 10 (11.9) 0.021
 Liver diseases, n (%) 4 (3.4) 11 (13.1) 0.01
 Malignancy, n (%) 4 (3.4) 10 (11.9) 0.02
 COPD, n (%) 5 (4.3) 4 (4.8) 1.0
 Thyroid disorders, n (%) 4 (3.4) 2 (2.4) 1.00
 Urinary system, n (%) 8 (6.9) 1 (1.2) 0.08
 Others, n (%) 7 (6) 2 (2.4) 0.30
AKI stages
 Stage I, n (%) 21 (18.1) 6 (7.1) 0.024
 Stage II, n (%) 30 (25.9) 6 (7.1) 0.0007
 Stage III, n (%) 65 (56) 72 (85.7) 0.0001
Age-groups
 <30 years, n (%) 17 (14.7) 3 (3.6) 0.008
 30–60 years, n (%) 57 (49.1) 36 (42.9) 0.38
 >60 years, n (%) 42 (36.2) 45 (53.6) 0.01
Etiology
 Sepsis, n (%) 13 (11.2) 53 (63.1) 0.0001
 Infections, n (%) 51 (44) 14 (16.7) 0.0001
 Post-surgery, n (%) 17 (14.6) 38 (45.2) <0.0001
 Cardiovascular disease, n (%) 6 (5.2) 1 (1.2) 0.24
 Liver disease, n (%) 4 (3.4) 9 (10.7) 0.04
 Drug induced, n (%) 11 (9.5) 0 0.003
 Poisoning, n (%) 0 4 (4.7) 0.018
 Malignancy, n (%) 4 (3.4) 6 (7.1) 0.23
 Alcohol abuse, n (%) 5 (4.3) 0 0.075
 Neurological, n (%) 7 (6) 27 (32.1) 0.0001
Laboratory parameters
 BMI median (range) 24.6 (21.9–32.5) 24.1 (18.1–29) 0.15
 BSA median (range) 1.85 (1.54–2.03) 1.84 (1.51–2.04) 0.17
 SOFA score median (range) 8 (1–16) 12 (2–18) 0.0001
 Urine output median (range) 0.4 (0.1–0.6) 0.3 (0.1–0.6) 0.02
 GFR median (range) 36 (5–123) 24 (4–107) 0.004
RRT
 RRT requirement on admission, n (%) 16 (13.8) 25 (29.8) 0.0058
Mechanical ventilation
 Mechanical ventilation given on admission 18 (15.52) 66 (78.6) 0.0001
Inotrope requirement
 Inotrope not required, n (%) 30 (25.9) 8 (9.5) 0.003
 Inotrope given = 1, n (%) 74 (63.8) 36 (42.9) 0.003
 Inotrope given = 2, n (%) 12 (10.3) 32 (38.1) <0.0001
 Inotrope given = 3, n (%) 0 8 (9.5) 0.0007

AKI, acute kidney injury; BMI, body mass index; BSA, body surface area; COPD, chronic obstructive pulmonary disease; GFR, glomerular filtration rate; RRT, renal replacement therapy; SOFA, sequential organ failure assessment